|Articles|July 1, 1997

July 1997
Volume 3
Issue 7

Managed Care Guidelines for the Economic Evaluation of Pharmaceuticals

Author(s)Paul C. Langley, PhD, Robert E. Martin, MS, RPh

Download PDF: Managed Care Guidelines for the Economic Evaluation of Pharmaceuticals

Articles in this issue

over 28 years ago

Article

Comparison of Intranasal Triamcinolone Acetonide with Oral Loratadine in the Treatment of Seasonal Ragweed-Induced Allergic Rhinitis

over 28 years ago

Article

Lyme Disease: Recognition, Management, and Prevention in the Primary Care Setting

over 28 years ago

Article

Osteoporosis: Review of Guidelines and Consensus Statements

over 28 years ago

Article

Innovation, One Step at a Time: Same-Day Ileostomy Closure

over 28 years ago

Article

Correspondence regarding, "HMOs and the Efficiency of Healthcare Delivery"

over 28 years ago

Article

Same-Day Surgery Ileostomy Closure?

over 28 years ago

Article

Pharmacoeconomic Analysis of Selected Antibiotics in Lower Respiratory Tract Infection

over 28 years ago

Article

Clinical Improvement with Bottom-Line Impact: Custom Care Planning for Patients with Acute and Chronic Illnesses in a Managed Care Setting

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!

Related Content

HEDIS Glycemic Goal Achieved Using Control-IQ Technology

ByBimal V. Patel, PharmD, MS,Sharon M. Wang, PharmD, MS,Laurel H. Messer, PhD, MPH, RN, CDCES, BC-ADM,Jordan E. Pinsker, MD,Miranda R. Polin, MS, BS,Irl B. Hirsch, MD,Laya Ekhlaspour, MD,Steve Edelman, MD,Diana I. Brixner, PhD, RPh,Charles Stemple, DO

December 22nd 2025

Linking Data to Determine Risk for 30-Day Readmissions in Dementia

ByPamela S. Roberts, PhD, OTR/L,Chih-Ying Li, PhD, OTR/L,Debra S. Ouellette, MS, OTR/L,Nabeel Qureshi, MPH,Erica Spivack, MHA,Mary Nasmyth, MD,Nancy L. Sicotte, MD,Zaldy S. Tan, MD

December 22nd 2025

Performance of 2-Stage Health-Related Social Needs Screening Using Area-Level Measures

ByJoshua R. Vest, PhD, MPH,Christopher A. Harle, PhD,Justin Blackburn, PhD

December 19th 2025

Impact of Medicaid Institution for Mental Diseases Exclusion on Serious Mental Illness Outcomes

ByOnur Baser, PhD, MS,Heidi C. Waters, PhD,Nehir Yapar, BS,Katarzyna Rodchenko, MA, MPH,Lauren Isenman, MPH,Xue Han, PhD,Deborah Freedman, MBA,Rashmi Patel, MD, PhD

December 17th 2025

Physician-Pharmacy Integration in Cancer Care: Pillars of Medically Integrated Pharmacy

ByGury K. Doshi, MD,Lucio Gordan, MD,Kirollos Hanna, PharmD,Scott Freeswick, PharmD,Natalie Dickson, MD,Desi Kotis, PharmD,Osama Abdelghany, PharmD, MHA,Ken Komorny, PharmD,Neal Dave, PharmD,Michael Reff, RPh, MBA

Managed Care Guidelines for the Economic Evaluation of Pharmaceuticals

Articles in this issue

Newsletter

Related Content

HEDIS Glycemic Goal Achieved Using Control-IQ Technology

Linking Data to Determine Risk for 30-Day Readmissions in Dementia

Performance of 2-Stage Health-Related Social Needs Screening Using Area-Level Measures

Impact of Medicaid Institution for Mental Diseases Exclusion on Serious Mental Illness Outcomes

Physician-Pharmacy Integration in Cancer Care: Pillars of Medically Integrated Pharmacy

Trending on AJMC

ICYMI: Highlights From ASH 2025

Top 5 Most-Read Dermatology Content of 2025

Top 5 Most-Read CLL Articles of 2025

Top 5 Most-Read "5 Things" Articles of 2025

Visibility, Not Lesion Burden, Drives Distress in Alopecia Areata